Predictive Oncology Inc.

1.47
0.02 (1.38%)
At close: Mar 31, 2025, 11:32 AM

Predictive Oncology Statistics

Share Statistics

Predictive Oncology has 7.21M shares outstanding. The number of shares has increased by 64.09% in one year.

Shares Outstanding 7.21M
Shares Change (YoY) 64.09%
Shares Change (QoQ) 0%
Owned by Institutions (%) 0%
Shares Floating 7.1M
Failed to Deliver (FTD) Shares 3.21K
FTD / Avg. Volume 0.07%

Short Selling Information

The latest short interest is 148.96K, so 2.23% of the outstanding shares have been sold short.

Short Interest 148.96K
Short % of Shares Out 2.23%
Short % of Float 2.28%
Short Ratio (days to cover) 1.26

Valuation Ratios

The PE ratio is -0.94 and the forward PE ratio is -11.33. Predictive Oncology's PEG ratio is 0.01.

PE Ratio -0.94
Forward PE -11.33
PS Ratio 7.42
Forward PS 0.3
PB Ratio 1.6
P/FCF Ratio -0.98
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Predictive Oncology Inc. has an Enterprise Value (EV) of 7.34M.

EV / Earnings -0.52
EV / Sales 4.12
EV / EBITDA -0.56
EV / EBIT -0.52
EV / FCF -0.54

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.35.

Current Ratio 2.55
Quick Ratio 2.43
Debt / Equity 0.35
Total Debt / Capitalization 25.67
Cash Flow / Debt -4.62
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -1.69% and return on capital (ROIC) is -126.56%.

Return on Equity (ROE) -1.69%
Return on Assets (ROA) -0.97%
Return on Capital (ROIC) -126.56%
Revenue Per Employee $52,355.68
Profits Per Employee $-411,293.15
Employee Count 34
Asset Turnover 0.12
Inventory Turnover 1.28

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -43.14% in the last 52 weeks. The beta is 1.22, so Predictive Oncology's price volatility has been higher than the market average.

Beta 1.22
52-Week Price Change -43.14%
50-Day Moving Average 1.36
200-Day Moving Average 1.03
Relative Strength Index (RSI) 56.27
Average Volume (20 Days) 4.78M

Income Statement

In the last 12 months, Predictive Oncology had revenue of 1.78M and earned -13.98M in profits. Earnings per share was -3.48.

Revenue 1.78M
Gross Profit 1.15M
Operating Income -14.08M
Net Income -13.98M
EBITDA -13.18M
EBIT -14.08M
Earnings Per Share (EPS) -3.48
Full Income Statement

Balance Sheet

The company has 8.73M in cash and 2.86M in debt, giving a net cash position of 5.87M.

Cash & Cash Equivalents 8.73M
Total Debt 2.86M
Net Cash 5.87M
Retained Earnings -167.76M
Total Assets 7.5M
Working Capital 750.64K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.19M and capital expenditures -302.37K, giving a free cash flow of -13.49M.

Operating Cash Flow -13.19M
Capital Expenditures -302.37K
Free Cash Flow -13.49M
FCF Per Share -3.36
Full Cash Flow Statement

Margins

Gross margin is 64.34%, with operating and profit margins of -791.21% and -785.58%.

Gross Margin 64.34%
Operating Margin -791.21%
Pretax Margin -785.58%
Profit Margin -785.58%
EBITDA Margin -740.52%
EBIT Margin -791.21%
FCF Margin -757.92%

Dividends & Yields

POAI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -240%
FCF Yield -129.06%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for POAI.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Apr 24, 2023. It was a backward split with a ratio of 1:20.

Last Split Date Apr 24, 2023
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -37.61
Piotroski F-Score 3